Kimia Farma Persero Tbk - Asset Resilience Ratio
Kimia Farma Persero Tbk (KAEF) has an Asset Resilience Ratio of 0.08% as of March 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Kimia Farma Persero Tbk total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2002–2024)
This chart shows how Kimia Farma Persero Tbk's Asset Resilience Ratio has changed over time. See KAEF total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Kimia Farma Persero Tbk's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see KAEF market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rp12.77 Billion | 0.08% |
| Short-term Investments | Rp0.00 | 0% |
| Total Liquid Assets | Rp12.77 Billion | 0.08% |
Asset Resilience Insights
- Limited Liquidity: Kimia Farma Persero Tbk maintains only 0.08% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Kimia Farma Persero Tbk Industry Peers by Asset Resilience Ratio
Compare Kimia Farma Persero Tbk's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sigma Healthcare Ltd
AU:SIG |
Medical Distribution | 0.03% |
|
Cyclopharm Ltd
AU:CYC |
Medical Distribution | 1.98% |
|
Ebos Group Ltd
AU:EBO |
Medical Distribution | 0.00% |
|
Paragon Care Ltd
AU:PGC |
Medical Distribution | 0.00% |
|
Mayne Pharma Group Ltd
AU:MYX |
Medical Distribution | 4.00% |
|
Profarma Distribuidora de Produtos Farmacêuticos S.A
SA:PFRM3 |
Medical Distribution | 4.48% |
|
Shanghai Pharmaceuticals Holding Co Ltd
SHG:601607 |
Medical Distribution | 4.44% |
|
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SHG:600332 |
Medical Distribution | 5.56% |
Annual Asset Resilience Ratio for Kimia Farma Persero Tbk (2002–2024)
The table below shows the annual Asset Resilience Ratio data for Kimia Farma Persero Tbk.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 0.27% | Rp40.37 Billion ≈ $2.37 Million |
Rp14.97 Trillion ≈ $877.01 Million |
+0.25pp |
| 2023-12-31 | 0.02% | Rp3.37 Billion ≈ $197.26K |
Rp17.59 Trillion ≈ $1.03 Billion |
+5.34pp |
| 2022-12-31 | -5.33% | Rp-1.08 Trillion ≈ $-63.52 Million |
Rp20.35 Trillion ≈ $1.19 Billion |
+0.81pp |
| 2021-12-31 | -6.13% | Rp-1.09 Trillion ≈ $-63.82 Million |
Rp17.76 Trillion ≈ $1.04 Billion |
+0.82pp |
| 2020-12-31 | -6.95% | Rp-1.22 Trillion ≈ $-71.57 Million |
Rp17.56 Trillion ≈ $1.03 Billion |
-0.06pp |
| 2019-12-31 | -6.89% | Rp-1.26 Trillion ≈ $-74.11 Million |
Rp18.35 Trillion ≈ $1.08 Billion |
+4.79pp |
| 2018-12-31 | -11.68% | Rp-1.11 Trillion ≈ $-64.75 Million |
Rp9.46 Trillion ≈ $554.34 Million |
-21.65pp |
| 2017-12-31 | 9.97% | Rp607.94 Billion ≈ $35.62 Million |
Rp6.10 Trillion ≈ $357.21 Million |
+20.76pp |
| 2016-12-31 | -10.79% | Rp-497.60 Billion ≈ $-29.16 Million |
Rp4.61 Trillion ≈ $270.28 Million |
-5.11pp |
| 2015-12-31 | -5.68% | Rp-183.75 Billion ≈ $-10.77 Million |
Rp3.24 Trillion ≈ $189.63 Million |
-0.78pp |
| 2014-12-31 | -4.90% | Rp-145.49 Billion ≈ $-8.53 Million |
Rp2.97 Trillion ≈ $173.92 Million |
-0.44pp |
| 2013-12-31 | -4.46% | Rp-110.30 Billion ≈ $-6.46 Million |
Rp2.47 Trillion ≈ $144.85 Million |
-1.09pp |
| 2012-12-31 | -3.37% | Rp-70.02 Billion ≈ $-4.10 Million |
Rp2.08 Trillion ≈ $121.67 Million |
-3.71pp |
| 2004-12-31 | 0.34% | Rp4.00 Billion ≈ $234.38K |
Rp1.17 Trillion ≈ $68.76 Million |
-5.89pp |
| 2003-12-31 | 6.23% | Rp85.11 Billion ≈ $4.99 Million |
Rp1.37 Trillion ≈ $80.09 Million |
+3.54pp |
| 2002-12-31 | 2.68% | Rp27.86 Billion ≈ $1.63 Million |
Rp1.04 Trillion ≈ $60.85 Million |
-- |
About Kimia Farma Persero Tbk
PT Kimia Farma Tbk engages in the research, development, manufacture, and sale of pharmaceutical products in Indonesia and internationally. It offers generic drugs and ethical products; over-the-counter products and herbs; and cosmetic products. The company also provides integrated health clinic and medical laboratory services; operates a beauty clinic; and retails pharmaceutical products, as wel… Read more